Translating Scientific Discovery Into Health Policy Impact: Innovative Bibliometrics Bridge Translational Research Publications to Policy Literature
暂无分享,去创建一个
[1] Martin Szomszor,et al. Overton: A bibliometric database of policy document citations , 2022, Quantitative Science Studies.
[2] K. Emmons,et al. Embracing policy implementation science to ensure translation of evidence to cancer control policy. , 2021, Translational behavioral medicine.
[3] T. Kuchenmüller,et al. Translating health information into policy-making: A pragmatic framework. , 2021, Health policy.
[4] Christopher P. Austin. Opportunities and challenges in translational science , 2021, Clinical and translational science.
[5] Étienne Vignola-Gagné,et al. A large-scale validation of the relationship between cross-disciplinary research and its uptake in policy-related documents, using the novel Overton altmetrics database , 2021, Quantitative Science Studies.
[6] S. Woolf,et al. Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021. , 2021, JAMA.
[7] A. Fitzpatrick,et al. Big splashes & ripple effects: a narrative review of the short- & long-term impact of publications supported by an NIH CTSA pediatrics program , 2021, Translational pediatrics.
[8] Kalene Morozumi,et al. Evaluating a CTSA-funded pilot grant program , 2020, Journal of Clinical and Translational Science.
[9] Dorothy R Carter,et al. Using the payback framework to evaluate the outcomes of pilot projects supported by the Georgia Clinical and Translational Science Alliance , 2020, Journal of Clinical and Translational Science.
[10] Dorothy R. Carter,et al. Scope, Influence, and Interdisciplinary Collaboration: The Publication Portfolio of the NIH Clinical and Translational Science Awards (CTSA) Program From 2006 Through 2017 , 2020, Evaluation & the health professions.
[11] J. Mascola,et al. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.
[12] Roy T Sabo,et al. Excess Deaths From COVID-19 and Other Causes, March-April 2020. , 2020, JAMA.
[13] J. Buse,et al. Bibliometrics approach to evaluating the research impact of CTSAs: A pilot study , 2020, Journal of Clinical and Translational Science.
[14] S. Woolf,et al. Life Expectancy and Mortality Rates in the United States, 1959-2017. , 2019, JAMA.
[15] Sidney C. Smith,et al. 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2019, Circulation. Cardiovascular quality and outcomes.
[16] George M. Santangelo,et al. Predicting translational progress in biomedical research , 2019, PLoS biology.
[17] Christopher P. Austin,et al. The Fundamental Characteristics of a Translational Scientist. , 2019, ACS pharmacology & translational science.
[18] Dorothy R. Carter,et al. Charting the Publication and Citation Impact of the NIH Clinical and Translational Science Awards (CTSA) Program From 2006 Through 2016 , 2018, Academic medicine : journal of the Association of American Medical Colleges.
[19] S. Elmore,et al. The Altmetric Attention Score: What Does It Mean and Why Should I Care? , 2018, Toxicologic pathology.
[20] C. Escoffery,et al. Building diverse careers in clinical and translational research: Evaluation of a certificate program in translational research , 2018, Journal of Clinical and Translational Science.
[21] Harvey A. Whiteford,et al. How do we define the policy impact of public health research? A systematic review , 2017, Health Research Policy and Systems.
[22] Amy M. Suiter,et al. The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences , 2017, Clinical and translational science.
[23] Ariela M. Freedman,et al. Improving clinical and translational research training: a qualitative evaluation of the Atlanta Clinical and Translational Science Institute KL2-mentored research scholars program , 2016, Journal of Investigative Medicine.
[24] George M. Santangelo,et al. Relative Citation Ratio (RCR): A New Metric That Uses Citation Rates to Measure Influence at the Article Level , 2015, bioRxiv.
[25] Bill Bynum,et al. Lancet , 2015, The Lancet.
[26] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[27] B. Stoll,et al. Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective Cohort Study , 2011, PLoS medicine.
[28] Robert M Califf,et al. Linking Scientific Discovery and Better Health for the Nation: The First Three Years of the NIH's Clinical and Translational Science Awards , 2010, Academic medicine : journal of the Association of American Medical Colleges.
[29] Dwight J Rouse,et al. A multicenter, randomized trial of treatment for mild gestational diabetes. , 2009, The New England journal of medicine.
[30] Miguel Angel Martin-Piedra,et al. Methods for identifying biomedical translation: a systematic review. , 2022, American journal of translational research.
[31] C. Escobar Cervantes,et al. [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.
[32] Euan Adie,et al. The rise of altmetrics , 2015 .
[33] Mary Lyn Gaffield,et al. Grading of Recommendations Assessment, Development, and Evaluation (GRADE) , 2011 .